4.3 Article

Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico

Ana Basto-Abreu et al.

Summary: This study estimated the national and regional seroprevalence of SARS-CoV-2 antibodies in Mexico after the first wave from August to November 2020. The national seroprevalence was 24.9%, with lower rates among adults aged 60 and older. Higher seroprevalence was found in urban and metropolitan areas, low socioeconomic status, low education levels, and among workers. Among those with antibodies, 67.3% were asymptomatic. These findings highlight the importance of considering vulnerable groups in social distancing, lockdown measures, and vaccination programs.

NATURE COMMUNICATIONS (2022)

Article Immunology

Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021

Vanessa C. Nicolete et al.

Summary: The emergence of the Gamma variant of SARS-CoV-2 does not seem to have affected the age-specific attack rates and proportions of symptomatic infections in the Brazilian Amazon region.

EMERGING INFECTIOUS DISEASES (2022)

Review Immunology

A systematic review of asymptomatic infections with COVID-19

Zhiru Gao et al.

Summary: Since the outbreak of COVID-19 at the end of December 2019, it has caused significant harm and challenges to over 200 countries and regions worldwide. Many patients with COVID-19 are asymptomatic or have only mild symptoms, yet they can still spread the virus, making screening for asymptomatic infections difficult and complicating national prevention and control efforts.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Editorial Material Public, Environmental & Occupational Health

Digital public interest on coronavirus information and social distancing: a Brazilian nationwide analysis using an infodemiology approach

Paulo Ricardo Martins-Filho et al.

JOURNAL OF TRAVEL MEDICINE (2021)

Review Infectious Diseases

Update on SARS-CoV-2 seroprevalence: regional and worldwide

Ali Rostami et al.

Summary: This study conducted a global systematic review and meta-analysis to estimate the global and regional SARS-CoV-2 seroprevalences, finding a global pooled seroprevalence of approximately 9.47% with significant heterogeneity. The highest and lowest seroprevalences were observed in Central and Southern Asia, as well as Eastern and South-eastern Asia. The study suggests that by mid-2021, the majority of the world's population remained highly susceptible to SARS-CoV-2 infection.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Medicine, General & Internal

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Kristina L. Bajema et al.

Summary: This cross-sectional study indicates that as of September 2020, most people in the US did not have serologic evidence of previous SARS-CoV-2 infection, although the prevalence varied widely by jurisdiction. Seroprevalence surveys showed variations in infection rates between different sexes, age groups, and metropolitan/nonmetropolitan areas.

JAMA INTERNAL MEDICINE (2021)

Article Public, Environmental & Occupational Health

Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil

Aluisio J. D. Barros et al.

Summary: The study found that the seropositivity rate increased from 0.07% in early April 2020 to 18.2% in April 2021, with significant variations among different racial groups and levels of exposure. The proportion of the population infected by SARS-CoV-2 in the state is still far from achieving herd immunity, indicating the need for continued public health interventions.

REVISTA DE SAUDE PUBLICA (2021)

Article Public, Environmental & Occupational Health

Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study

Adriano Antunes de Souza Araujo et al.

Summary: A study in Sergipe state, Northeast Brazil showed a seroprevalence of 9.3% for COVID-19, with slightly higher rates in women compared to men. While there was a decline in SARS-CoV-2 antibody prevalence with age, the differences were not statistically significant. Metropolitan areas had a higher seroprevalence compared to municipalities outside the city.

EPIDEMIOLOGY AND INFECTION (2021)

Letter Public, Environmental & Occupational Health

SARS-CoV-2 genomic surveillance in Northeast Brazil: timing of emergence of the Brazilian variant of concern P1

Cliomar Alves dos Santos et al.

Summary: Since March 2020, 11 lineages of severe acute respiratory syndrome coronavirus 2 have been identified in Sergipe state, Northeast Brazil. During the first 6 months of the COVID-19 outbreak, there was a higher frequency of B.1 and B.1.1.33 lineages. During the second wave, there was an increased frequency of the new Brazilian variant of concern, P.1.

JOURNAL OF TRAVEL MEDICINE (2021)

Article Biochemistry & Molecular Biology

COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence

Felipe Gomes Naveca et al.

Summary: Analysis of circulating SARS-CoV-2 viruses during the first and second waves of COVID-19 in Amazonas, Brazil, shows successive lineage replacements led to predominance of the variant of concern P.1 and are associated with variable levels of social distancing.

NATURE MEDICINE (2021)

Review Multidisciplinary Sciences

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis

Niklas Bobrovitz et al.

Summary: A systematic review and meta-analysis of 968 seroprevalence studies with 9.3 million participants from 74 countries found significant variations in SARS-CoV-2 antibody prevalence among different populations. Ethnic minorities and certain age groups were more likely to test positive for antibodies. National studies reported lower seroprevalence estimates compared to regional and local studies, with considerable variation across regions.

PLOS ONE (2021)

Letter Public, Environmental & Occupational Health

Relationship between population density and COVID-19 incidence and mortality estimates: A county-level analysis

Paulo R. Martins-Filho

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

Article Health Care Sciences & Services

Deaths From COVID-19 in Rural, Micropolitan, and Metropolitan Areas: A County-Level Comparison

Saleema A. Karim et al.

Summary: This study investigated the differences in COVID-19 death rates between urban and rural areas in the United States, finding that rural counties had significantly lower death rates compared to metropolitan counties. Rural areas need to develop proactive prevention strategies and response plans to control the spread of COVID-19.

JOURNAL OF RURAL HEALTH (2021)

Review Infectious Diseases

Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review

Chih-Cheng Lai et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Editorial Material Medicine, General & Internal

The Power of Antibody-Based Surveillance

Galit Alter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Spreading of COVID-19: Density matters

David W. S. Wong et al.

PLOS ONE (2020)

Review Infectious Diseases

Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible

Lea A. Nikolai et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Regional & Urban Planning

Does Density Aggravate the COVID-19 Pandemic? Early Findings and Lessons for Planners

Shima Hamidi et al.

JOURNAL OF THE AMERICAN PLANNING ASSOCIATION (2020)

Article Immunology

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019

Hongyan Hou et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)